Submitted by Anonymous (not verified) on 13 July 2026 - 14:38
Human medicines European public assessment report (EPAR): Abasaglar (previously Abasria), insulin glargine, Date of authorisation: 09/09/2014, Revision: 14, Status: Authorised
Source: